Today on HITshow:



U.S. News & World Report unveils the 2025–2026 Best Children’s Hospitals rankings, spotlighting excellence and access in pediatric care. Plus: Valley Children’s proves AI delivers measurable ROI, Kaiser braces for a multi-state strike, Qualtrics buys Press Ganey in a $6.7B experience data deal, Talkspace adds Wisdo Health for peer connection, and this year’s Nobel Prize honors breakthroughs in immune regulation.



HOST: IDA KLEIN



???? October 7, 2025



???? Feature — Ida KleinU.S. News & World Report releases its 2025–2026 Best Children’s Hospitals Rankings, offering new insight into pediatric excellence across 11 specialties — and growing attention to behavioral health, access, and equity. Managing Editor Ben Harder joins HITshow to explain how the data-driven analysis helps families and clinicians make informed decisions about care.



???? Providers — Teresa VaughnAt Valley Children’s Hospital, artificial intelligence is delivering measurable ROI — cutting wait times, improving sepsis detection, and optimizing staffing decisions through predictive analytics embedded in daily operations.



???? Workforce & Culture — Peter BetterworthKaiser Permanente faces a potential multi-state strike involving more than 75,000 workers, as contract negotiations stall over staffing and pay. Analysts warn the standoff could signal wider workforce stress as health systems enter Q4.



???? Finance & M&A — Logan StokesQualtrics acquires Press Ganey in a $6.7 billion deal that fuses experience management with clinical quality data. The move aims to connect satisfaction, safety, and outcomes — turning patient experience into a measurable driver of performance.



???? Telehealth & Remote Care — Jade RomeroTalkspace acquires Wisdo Health, adding AI-guided peer communities to its mental health platform. The deal expands Talkspace’s model beyond therapy sessions — blending community, coaching, and behavioral engagement in a unified ecosystem.



???? Science & Discovery — Jalen CrossThe 2025 Nobel Prize in Medicine goes to Dr. Jeffrey Bluestone (UCSF) and Dr. Shimon Sakaguchi (Osaka University) for identifying regulatory T cells, unlocking new therapies for autoimmune diseases and advancing precision immunology.



???? Subscribe here or wherever you listen to podcasts, and if you like our show, please follow us on LinkedIn at https://www.linkedin.com/company/hit.show.



HITshow is made possible by HLTH 2025.

Ver todos los episodios